Edwards Lifesciences Price to Book Ratio 2012-2026 | EW
Historical price to book ratio values for Edwards Lifesciences (EW) over the last 10 years. The current price to book ratio for Edwards Lifesciences as of September 18, 2026 is 4.74.
| Edwards Lifesciences Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-09-18 | 88.26 | 4.75 | |
| 2026-06-30 | 90.46 | $18.60 | 4.86 |
| 2026-03-31 | 80.08 | $17.90 | 4.47 |
| 2025-12-31 | 85.25 | $17.80 | 4.79 |
| 2025-09-30 | 77.77 | $17.57 | 4.43 |
| 2025-06-30 | 78.21 | $18.04 | 4.34 |
| 2025-03-31 | 72.48 | $17.39 | 4.17 |
| 2024-12-31 | 74.03 | $17.10 | 4.33 |
| 2024-09-30 | 65.99 | $16.30 | 4.05 |
| 2024-06-30 | 92.37 | $12.46 | 7.41 |
| 2024-03-31 | 95.56 | $11.93 | 8.01 |
| 2023-12-31 | 76.25 | $11.18 | 6.82 |
| 2023-09-30 | 69.28 | $11.09 | 6.25 |
| 2023-06-30 | 94.33 | $10.60 | 8.90 |
| 2023-03-31 | 82.73 | $10.00 | 8.27 |
| 2022-12-31 | 74.61 | $9.55 | 7.82 |
| 2022-09-30 | 82.63 | $10.04 | 8.23 |
| 2022-06-30 | 95.09 | $9.59 | 9.92 |
| 2022-03-31 | 117.72 | $9.41 | 12.52 |
| 2021-12-31 | 129.55 | $9.35 | 13.85 |
| 2021-09-30 | 113.21 | $8.88 | 12.75 |
| 2021-06-30 | 103.57 | $8.24 | 12.57 |
| 2021-03-31 | 83.64 | $7.49 | 11.16 |
| 2020-12-31 | 91.23 | $7.33 | 12.45 |
| 2020-09-30 | 79.82 | $6.76 | 11.81 |
| 2020-06-30 | 69.11 | $6.18 | 11.19 |
| 2020-03-31 | 62.87 | $6.30 | 9.98 |
| 2019-12-31 | 77.76 | $19.84 | 3.92 |
| 2019-09-30 | 73.30 | $6.10 | 12.02 |
| 2019-06-30 | 61.58 | $5.61 | 10.97 |
| 2019-03-31 | 63.78 | $5.51 | 11.57 |
| 2018-12-31 | 51.06 | $5.04 | 10.13 |
| 2018-09-30 | 58.03 | $5.36 | 10.83 |
| 2018-06-30 | 48.52 | $5.04 | 9.62 |
| 2018-03-31 | 46.51 | $5.13 | 9.06 |
| 2017-12-31 | 37.57 | $4.70 | 8.00 |
| 2017-09-30 | 36.44 | $4.98 | 7.31 |
| 2017-06-30 | 39.41 | $4.64 | 8.49 |
| 2017-03-31 | 31.36 | $4.35 | 7.22 |
| 2016-12-31 | 31.23 | $4.13 | 7.57 |
| 2016-09-30 | 40.19 | $4.20 | 9.57 |
| 2016-06-30 | 33.24 | $3.87 | 8.58 |
| 2016-03-31 | 29.40 | $3.62 | 8.13 |
| 2015-12-31 | 26.33 | $3.87 | 6.80 |
| 2015-09-30 | 23.70 | $3.75 | 6.32 |
| 2015-06-30 | 23.74 | $3.55 | 6.68 |
| 2015-03-31 | 23.74 | $3.43 | 6.92 |
| 2014-12-31 | 21.23 | $6.78 | 3.13 |
| 2014-09-30 | 17.03 | $3.19 | 5.34 |
| 2014-06-30 | 14.31 | $3.01 | 4.75 |
| 2014-03-31 | 12.36 | $2.12 | 5.82 |
| 2013-12-31 | 10.96 | $2.36 | 4.65 |
| 2013-09-30 | 11.61 | $2.19 | 5.30 |
| 2013-06-30 | 11.20 | $2.35 | 4.77 |
| 2013-03-31 | 13.69 | $2.34 | 5.86 |
| 2012-12-31 | 15.03 | $2.16 | 6.97 |
| 2012-09-30 | 17.90 | $2.21 | 8.11 |
| 2012-06-30 | 17.22 | $2.07 | 8.30 |
| 2012-03-31 | 12.12 | $2.03 | 5.96 |
| 2011-12-31 | 11.78 | $1.95 | 6.03 |
| 2011-09-30 | 11.88 | $1.98 | 6.01 |
| 2011-06-30 | 14.53 | $2.01 | 7.23 |
| 2011-03-31 | 14.50 | $1.97 | 7.36 |
| 2010-12-31 | 13.47 | $1.90 | 7.11 |
| 2010-09-30 | 11.18 | $1.80 | 6.20 |
| 2010-06-30 | 9.34 | $1.65 | 5.67 |
| 2010-03-31 | 8.24 | $1.69 | 4.88 |
| 2009-12-31 | 7.24 | $3.40 | 2.13 |
| 2009-09-30 | 5.83 | $1.61 | 3.62 |
| 2009-06-30 | 5.67 | $1.48 | 3.83 |
| 2009-03-31 | 5.05 | $1.40 | 3.60 |
| 2008-12-31 | 4.58 | $1.31 | 3.50 |
| 2008-09-30 | 4.81 | $1.30 | 3.69 |
| 2008-06-30 | 5.17 | $1.32 | 3.91 |
| 2008-03-31 | 3.71 | $1.19 | 3.13 |
| 2007-12-31 | 3.83 | $1.23 | 3.12 |
| 2007-09-30 | 4.11 | $1.21 | 3.41 |
| 2007-06-30 | 4.11 | $1.17 | 3.51 |
| 2007-03-31 | 4.23 | $1.13 | 3.73 |
| 2006-12-31 | 3.92 | $1.08 | 3.62 |
| 2006-09-30 | 3.88 | $1.05 | 3.70 |
| 2006-06-30 | 3.79 | $1.03 | 3.67 |
| 2006-03-31 | 3.63 | $1.02 | 3.56 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $50.820B | $6.068B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $240.872B | 27.34 |
| Intuitive Surgical (ISRG) | United States | $138.955B | 47.11 |
| IQVIA Holdings (IQV) | United States | $43.853B | 23.45 |
| Waters (WAT) | United States | $41.424B | 30.82 |
| IDEXX Laboratories (IDXX) | United States | $40.308B | 35.98 |
| DexCom (DXCM) | United States | $33.717B | 35.04 |
| Alcon (ALC) | Switzerland | $32.170B | 19.95 |
| Mettler-Toledo (MTD) | United States | $27.898B | 31.02 |
| STERIS (STE) | Ireland | $19.991B | 19.68 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.827B | 0.00 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| Coloplast (CLPBY) | Denmark | $14.536B | 17.43 |
| Penumbra (PEN) | United States | $12.510B | 82.49 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.924B | 8.35 |
| Globus Medical (GMED) | United States | $9.946B | 15.06 |
| Glaukos (GKOS) | United States | $9.662B | 0.00 |
| Masimo (MASI) | United States | $9.578B | 30.69 |
| SARTORIUS (SSSGY) | Germany | $7.521B | 43.67 |
| Sysmex ADR (SSMXY) | Japan | $7.434B | 28.12 |
| Teleflex (TFX) | United States | $5.276B | 14.23 |
| LivaNova (LIVN) | United Kingdom | $4.298B | 21.73 |
| Integer Holdings (ITGR) | United States | $4.293B | 19.89 |
| Pulse Biosciences (PLSE) | United States | $3.814B | 0.00 |
| Veracyte (VCYT) | United States | $3.199B | 26.18 |
| TransMedics (TMDX) | United States | $2.987B | 43.87 |
| AxoGen (AXGN) | United States | $2.378B | 0.00 |
| UFP Technologies (UFPT) | United States | $2.143B | 27.05 |
| Elekta AB (EKTAY) | Sweden | $1.906B | 17.83 |
| Nihon Kohden (NHNKY) | Japan | $1.687B | 15.45 |
| Alphatec Holdings (ATEC) | United States | $1.572B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $1.377B | 0.00 |
| OPKO Health (OPK) | United States | $1.246B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.184B | 6.16 |
| Tandem Diabetes Care (TNDM) | United States | $1.174B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.171B | 27.77 |
| Artivion (AORT) | United States | $1.138B | 43.24 |
| PROCEPT BioRobotics (PRCT) | United States | $1.105B | 0.00 |
| IRadimed (IRMD) | United States | $1.050B | 45.88 |
| Beta Bionics (BBNX) | United States | $0.985B | 0.00 |
| SiBone (SIBN) | United States | $0.802B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.795B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.708B | 17.05 |
| AngioDynamics (ANGO) | United States | $0.638B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.570B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.559B | 1611.00 |
| Tactile Systems Technology (TCMD) | United States | $0.503B | 20.56 |
| NeuroPace (NPCE) | United States | $0.490B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.442B | 0.00 |
| 908 Devices (MASS) | United States | $0.435B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.426B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.422B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.355B | 0.00 |
| Mobia Medical (MOBI) | United States | $0.351B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Treace Medical Concepts (TMCI) | United States | $0.292B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.242B | 0.00 |
| Neuronetics (STIM) | United States | $0.221B | 0.00 |
| RxSight (RXST) | United States | $0.216B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.160B | 0.00 |
| FocalTherics (FOCL) | France | $0.156B | 0.00 |
| Inogen (INGN) | United States | $0.136B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.124B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.091B | 0.00 |
| LENSAR (LNSR) | United States | $0.087B | 0.00 |
| Hyperfine (HYPR) | United States | $0.083B | 0.00 |
| CVRx (CVRX) | United States | $0.081B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.076B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.073B | 24.09 |
| DarioHealth (DRIO) | United States | $0.071B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.058B | 0.00 |
| Positron (POSC) | United States | $0.058B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.056B | 0.00 |
| Envoy Medical (COCH) | United States | $0.055B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Vaso (VASO) | United States | $0.052B | 29.49 |
| Sensus Healthcare (SRTS) | United States | $0.050B | 0.00 |
| Precision Optics (POCI) | United States | $0.049B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.044B | 0.00 | |
| QT Imaging Holdings (QTI) | United States | $0.036B | 0.00 |
| InspireMD (NSPR) | United States | $0.036B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.032B | 0.00 |
| PAVmed (PAVM) | United States | $0.032B | 0.00 |
| Accuray (ARAY) | United States | $0.028B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.011B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| NexGel (NXGL) | United States | $0.003B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |